Research Article
Identification of Prognostic Genes in Neuroblastoma in Children by Weighted Gene Coexpression Network Analysis
Table 1
Clinical characteristics of NB patients in TARGET.
| | Characteristics | Number of cases (%) |
| | Gender = male | 87 (59.2) | | Age (days) (mean (SD)) | 1281.51 (1098.47) |
| | Vital status | | Alive | 75 (51.0) | | Dead | 72 (49.0) |
| | Overall survival time in days (mean (SD)) | 1730.50 (1120.27) |
| | INSS stage | | Stage 1 | 0 (0.0) | | Stage 2a | 0 (0.0) | | Stage 2b | 1 (0.7) | | Stage 3 | 6 (4.1) | | Stage 4 | 119 (81.0) | | Stage 4s | 21 (14.3) |
| | MYCN status | | Amplified | 30 (20.4) | | Not amplified | 117 (79.6) |
| | Ploidy | | Diploid (DI = 1) | 63 (42.9) | | Hyperdiploid (DI > 1) | 84 (57.1) |
| | Histology | | Favorable | 28 (19.0) | | Unfavorable | 110 (74.8) | | Unknown | 9 (6.1) |
| | Grade | | Differentiating | 10 (6.8) | | Undifferentiated or poorly differentiated | 115 (78.2) | | Unknown | 22 (15.0) |
| | MKI | | High | 32 (21.8) | | Intermediate | 40 (27.2) | | Low | 47 (32.0) | | Unknown | 28 (19.0) |
| | COG risk group | | High risk | 120 (81.6) | | Intermediate risk | 13 (8.8) | | Low risk | 14 (9.5) |
|
|
